Asia-Pacific LDL Test Market – Industry Trends and Forecast to 2026

  • In Vitro Diagnostics
  • Published Report
  • Jun 2019
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 24
  • No of Figures: 80

Asia-Pacific LDL Test Market By Component (Kits & Reagents, Devices, Services), Disease (Diabetes, Stroke, Atherosclerosis, Obesity, Dyslipidaemia, Carotid Artery Disease, Peripheral Arterial Disease, Angina, Others), Distribution Channel (Direct Tenders, Retail), End User (Hospitals, Clinics, Ambulatory Care, Research Laboratory), Country (China, Japan, India, Australia, South Korea, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific) – Industry Trends and Forecast to 2026

Low density lipoprotein (LDL) is known as bad cholesterol because it is build-up of extra fat in arteries. This condition narrows the arteries and raises the risk of heart attack, stroke and peripheral artery disease. So for the determination of LDL, various kits, reagent and devices are used. For instance N-geneous LDL cholesterol calibrator which used as LDL test for determination of low density lipoprotein for measuring risk of heart diseases. It is basically for in-vitro diagnostic use. These circular particles serve to solubilize and transport cholesterol and triglyceride in the blood stream. The relative proportions of protein and lipid calculates the density of this lipoprotein. The test LDL cholesterol acts as a key factor for determine pathogenesis of atherosclerosis and coronary heart disease. By the use of this test can easily find out associated risk for heart diseases.

Asia-Pacific LDL test market is projected to grow with a healthy CAGR in the forecast period of 2019 to 2026.

Segmentation: Asia-Pacific LDL Test Market

Asia-Pacific LDL test market is segmented into four notable segments such as component, disease, end user, distribution channel.

  • On the basis of component, the market is segmented into devices, kits & reagents and services. Devices are further segmented into spectrophotometer, syringes & needles, others.
  • On the basis of disease, the market is segmented into atherosclerosis, obesity, dyslipidemia, diabetes, angina, stroke, carotid artery disease, peripheral arterial disease, others.
  • On the basis of distribution channel, the market is segmented into direct tenders and retail.
  • On the basis of end user, the market is segmented into hospitals, clinics, research laboratory, and ambulatory care.

Competitive Analysis: Asia-Pacific LDL Test Market

Some of the major players operating in this market are Quest Diagnostics, Sekisui Diagnostics, Express Biotech International, Randox Laboratories Ltd, Reckondiagnostics, Diasys Diagnostic Systems GmbH, F. Hoffmann-La Roche Ltd, Abbott, Eurolyser Diagnostica GmbH, Sigma-Aldrich, Diazyme Laboratories, Inc., Laboratory Corporation of America, Cell Biolabs, Inc., Atlas Medical U.K, Eurofins Scientific, Thermo Fisher Scientific Inc., Home Access Health and others.

Product Launch

  • In October 2018, Laboratory Corporation of America (U.S) enabled health record on iPhone. This feature is beneficial for patients to access their LabCorp laboratory test results, along with other available medical data from multiple providers. It enables the patients in receiving the notifications when their data is updated. Patients can access other convenient tools including appointments and payment of invoices as well. With this innovative technology, the company enhances their business.
  • In September 2017, Quest Diagnostics (U.S) entered into cholesterol testing for identifying the risk of heart disease and opt right treatment decision. The company’s cholesterol test services which include an innovative calculation method to improve the accuracy of testing for LDL level causing cardiovascular disease.

Research Methodology: Asia-Pacific LDL Test Market

Primary Respondents: Key Opinion Leaders (KOL’s): Manufacturer, Healthcare Professionals, Doctors, Nurses, Medical practitioners. Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.


SKU-

LIST OF TABLES ASIA-PACIFIC LDL TEST MARKET

TABLE 1 ASIA-PACIFIC LDL TEST MARKET, BY COMPONENTS, 2017– 2026 (USD MILLION) TABLE 2 ASIA-PACIFIC KITS & REAGENTS IN ASIA-PACIFIC LDL TEST MARKET BY REGION, 2017-2026, USD MILLION TABLE 3 ASIA-PACIFIC DEVICES IN LDL TEST MARKET, BY COMPONENT, 2017-2026, USD MILLION TABLE 4 ASIA-PACIFIC DEVICES IN LDL TEST MARKET, BY REGION, 2017-2026, USD MILLION TABLE 5 ASIA-PACIFIC SERVICES IN ASIA-PACIFIC LDL TEST MARKET BY REGION, 2017-2026, USD MILLION TABLE 6 ASIA-PACIFIC LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 7 ASIA-PACIFIC DIABETES IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 8 ASIA-PACIFIC STROKE IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 9 ASIA-PACIFIC ATHEROSCLEROSIS IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 10 ASIA-PACIFIC OBESITY IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 11 ASIA-PACIFIC DYSLIPIDEMIA IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 12 ASIA-PACIFIC CAROTID ARTERY DISEASE IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 13 ASIA-PACIFIC PERIPHERAL ARTERIAL DISEASES IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 14 ASIA-PACIFIC ANGINA IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 15 ASIA-PACIFIC OTHERS IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 16 ASIA-PACIFIC LDL TEST MARKET, BY DRISTIBUTION CHANNEL, 2017– 2026 (USD MILLION) TABLE 17 ASIA-PACIFIC DIRECT TENTERS IN ASIA-PACIFIC LDL TEST MARKET, BY REGION, 2017-2026, USD MILLION TABLE 18 ASIA-PACIFIC RETAIL IN ASIA-PACIFIC LDL TEST MARKET, BY REGION, 2017-2026, USD MILLION TABLE 19 ASIA-PACIFIC LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 20 ASIA-PACIFIC HOSPITALS IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 21 ASIA-PACIFIC CLINICS IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 22 ASIA-PACIFIC AMBULATORY CARE IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 23 ASIA-PACIFIC RESEARCH LABORATORY IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 24 ASIA-PACIFIC LDL TEST MARKET, BY COUNTRY, 2017-2026 (USD MILLION) TABLE 25 ASIA-PACIFIC LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 26 ASIA-PACIFIC DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 27 ASIA-PACIFIC LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 28 ASIA-PACIFIC LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 29 ASIA-PACIFIC LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 30 CHINA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 31 CHINA DEVICES IN LDL TEST MARKET, BY COMPONENT, 2017-2026 (USD MILLION) TABLE 32 CHINA DEVICES IN LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 33 CHINA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 34 CHINA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 35 JAPAN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 36 JAPAN DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 37 JAPAN LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 38 JAPAN LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 39 JAPAN LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 40 INDIA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 41 INDIA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 42 INDIA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 43 INDIA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 44 INDIA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 45 AUSTRALIA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 46 AUSTRALIA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 47 AUSTRALIA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 48 AUSTRALIA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 49 AUSTRALIA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 50 SOUTH KOREA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 51 SOUTH KOREA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 52 SOUTH KOREA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 53 SOUTH KOREA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 54 SOUTH KOREA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 55 SINGAPORE LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 56 SINGAPORE DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 57 SINGAPORE LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 58 SINGAPORE LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 59 SINGAPORE LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 60 MALAYSIA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 61 MALAYSIA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 62 MALAYSIA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 63 MALAYSIA LDL TEST MARKET, BY DISTRIBUTION CHAANEL, 2017-2026 (USD MILLION) TABLE 64 MALAYSIA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 65 INDONESIA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 66 INDONESIA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 67 INDONESIA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 68 INDONESIA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 69 INDONESIA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 70 THAILAND LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 71 THAILAND DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 72 THAILAND LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 73 THAILAND LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 74 THAILAND LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 75 PHILIPPINES LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 76 PHILIPPINES DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 77 PHILIPPINES LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 78 PHILIPPINES LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 79 PHILIPPINES LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 80 REST OF APAC LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions